US2006189658A1PendingUtilityA1
Substituted pyrazoline compounds, their preparation and use as medicaments
Est. expiryFeb 17, 2024(expired)· nominal 20-yr term from priority
A61P 3/04A61P 43/00A61P 37/00A61P 9/00A61P 9/02A61P 7/08A61P 5/00A61P 3/10A61P 25/20A61P 25/22A61P 25/00A61P 27/06A61P 25/16A61P 25/08A61P 25/02A61P 25/32A61P 25/34A61P 25/18A61P 25/28A61P 25/30A61P 35/00A61P 25/14A61P 25/06A61P 25/04A61P 25/24A61P 25/36A61P 11/00A61P 19/00A61P 1/08A61P 19/10A61P 1/12A61P 17/04A61P 11/06C07D 231/06C07D 231/14C07D 401/12
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
Claims
exact text as granted — not AI-modified1 . N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-3-carboxamide.
2 . A method for the prophylaxis or treatment of a food intake disorder comprising administering the compound of claim 1 .
3 . The method of claim 2 wherein the disorder is selected from the group consisting of bulimia, anorexia, cachexia, obesity and type II diabetes mellitus (non-insulin dependent diabetes mellitus).
4 . A pharmaceutical composition comprising the compound of claim 1.Join the waitlist — get patent alerts
Track US2006189658A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.